MedTrace Logo

Caffeine Study for Pain Control Following Total Joint Replacement

NCT04280263 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-10-19

No results posted yet for this study

Summary

A prospective, double blinded, single center, randomized controlled study to evaluate the efficacy of caffeine in combination with acetyl salicylic acid (ASA) in the management of postoperative pain in patients undergoing total joint arthroplasty.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Caffeine

caffeine tables containing 150mg caffeine will be provided to patients with instructions to take twice per day

DRUG

Placebo oral tablet

oral placebo tablets matching the caffeine tablets and will be provided to patients with instructions to take twice per day

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-28
Primary Completion
2021-06-30
Completion
2021-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280263 on ClinicalTrials.gov